Weight loss medicines in England
A briefing on the licensing, regulation and supply of new weight loss medications in England.

This pack has been produced ahead of the general debate to be held in the Commons Chamber on Tuesday 10 October 2017 on Baby Loss Awareness Week.
Baby Loss Awareness Week (466 KB , PDF)
Baby Loss Awareness Week 2017 is on 9-15 October. This is an opportunity for those affected by baby loss to remember and commemorate their babies’ lives, and to raise awareness of this issue. The website provides more information about the aims of the week:
Baby Loss Awareness Week is an opportunity:
Together we are committed to raising awareness of pregnancy and baby loss. We also want to identify how we can reduce preventable deaths and improve support for all those affected.
Baby Loss Awareness week is coordinated and supported by a number of charities including Sands, the Miscarriage Association and Antenatal Results and Choices (ARC).
The term baby loss can describe a number of different types of bereavements including, miscarriage, ectopic pregnancy, stillbirth, neonatal and infant death, and termination of pregnancy. It is not possible to provide a comprehensive briefing on these in this debate pack. However, this briefing will highlight key recent policy announcements and parliamentary activity in this area.
A number of Commons library and POST publications may provide useful information in preparation for the debate on baby loss awareness week:
Baby Loss Awareness Week (466 KB , PDF)
A briefing on the licensing, regulation and supply of new weight loss medications in England.
Find out about the causes and consequences of medicines shortages, and UK Government actions in response to supply disruption affecting human medicines.
Interactive dashboard showing data on GPs in England, including patient to GP ratios, the number of GPs, and a map of GP practices